No new safety signals emerged after concomitant atogepant plus ubrogepant in patients with atogepant-refractory episodic migraine.

Preventing migraine chronification and medication overuse headache requires decreasing the number of migraine attacks and ...

Due to the possibility that many of the patients presenting with migraine may have had migraines in the past without diagnosis and proper treatment, researchers in this study aimed to analyze the ...

Mind+ Neurology is advancing medical research and offering hope to patients living with migraine. Mind+ is an authorized site for a new Episodic Migraine clinical trial.

Compared with placebo, galcanezumab was more effective in reducing dizziness among patients with vestibular migraine.

Eptinezumab vs placebo significantly reduces acute headache medication in patients with migraine and those with medication overuse.

The novel migraine-abortive agents lasmiditan, rimegepant, and ubrogepant effectively treated migraine pain in triptan-insufficient responders.

When I was a child, my mother suffered from horrible migraine headaches. Sometimes they were so bad that she'd have to close herself up in her bedroom for days with the shades drawn.

Chronic migraines are more than just bad headaches—they’re a serious condition that can affect your daily life. People who ...

There are more than 150 different types of headaches, ranging from a mild annoyance to a debilitating experience. Here's how ...

Methods: This systematic literature review gathered recent real-world evidence from Spain on the use of galcanezumab, a CGRP-targeting treatment, in migraine patients. The review included ...

Most people will pop a painkiller and hope the pain goes away quickly. But for migraine sufferers, the throbbing pain – usually on one side of the head, but often, on both sides – can be ...